Oroxylum indicum, sometimes called the Indian trumpet tree, has been used in Ayurvedic medicine for centuries. Modern extracts made from its bark or leaves are standardized for flavonoids such as baicalein, chrysin, and oroxylin A. These compounds are being investigated for potential benefits on memory, cognitive performance, inflammation, blood sugar balance, and general antioxidant protection.
In recent years, a standardized bark extract has been tested in adults with mild cognitive complaints, with encouraging results for episodic memory and certain attention tasks. At the same time, pre-clinical work has explored its effects on brain-derived neurotrophic factor (BDNF), oxidative stress, and neuroinflammation. Safety studies in animals suggest a relatively wide margin between typical supplemental intakes and doses that cause harm, but human data are still limited.
This guide walks you through what Oroxylum indicum extract is, how it may work, its potential benefits and uses, suggested dosage patterns, and known side effects and cautions, so you can discuss it more confidently with your healthcare professional.
Quick Overview for Oroxylum indicum extract
- Standardized Oroxylum indicum bark extract may support episodic memory, attention, and overall cognitive performance in adults with mild memory complaints.
- Experimental data suggest antioxidant, anti-inflammatory, neuroprotective, and possible metabolic benefits linked to baicalein, chrysin, and oroxylin A.
- Human trials most often use 500–1,000 mg per day of standardized extract, typically in divided doses with food.
- Mild digestive upset and headaches are the most commonly reported side effects; long-term human safety data remain limited.
- People who are pregnant or breastfeeding, have significant liver disease, or take sedatives, seizure medicines, or anticoagulants should avoid use unless closely supervised by a clinician.
Table of Contents
- What is Oroxylum indicum extract?
- How Oroxylum indicum extract works
- Benefits of Oroxylum indicum extract
- How to use Oroxylum indicum extract
- Oroxylum indicum extract dosage and timing
- Side effects, safety, and who should avoid it
- Research on Oroxylum indicum extract
What is Oroxylum indicum extract?
Oroxylum indicum is a small to medium-sized tree from the Bignoniaceae family, native to South and Southeast Asia. In Ayurveda it is known as Shyonaka or Sonapatha and appears in classic formulas such as Dashamoola and Chyawanprash. Traditional uses cover a wide range of complaints: respiratory conditions, joint pain, digestive upset, skin problems, fever, and general weakness.
Modern “Oroxylum indicum extract” usually refers to a standardized extract made from the stem bark (most common), though some products use leaves or fruits. The best-studied commercial preparations standardize the bark extract to specific levels of three flavonoids:
- Baicalein (often around 15%)
- Oroxylin A (around 10%)
- Chrysin (around 6%)
These flavonoids belong to the broader group of polyphenols, plant compounds with antioxidant and signaling effects in cells. Other constituents in the plant include tannins, saponins, glycosides, and phenolic acids, but most of the current research focuses on the flavonoid fraction.
It is important to distinguish between:
- Traditional crude decoctions or powders (where bark, roots, or fruits are boiled or dried and powdered, often combined with other herbs).
- Standardized extracts (typically alcohol or hydroalcoholic extracts, concentrated and adjusted so that each capsule contains a predictable amount of baicalein, chrysin, and oroxylin A).
The evidence discussed in this article refers mainly to standardized extracts, particularly one marketed for cognitive support. Crude preparations may have different potency, pharmacokinetics, and safety profiles.
In supplements, Oroxylum indicum extract is usually positioned as:
- A nootropic or cognitive support ingredient.
- An antioxidant and anti-inflammatory botanical.
- An Ayurvedic adaptogen component in multi-herb formulas.
Because not all products specify exact standardization, consumers often need to check labels carefully or contact manufacturers for detailed composition.
How Oroxylum indicum extract works
Oroxylum indicum extract appears to act through several overlapping mechanisms rather than a single pathway. Most of what we know comes from cell and animal studies, along with one completed human trial and emerging in vitro work on standardized bark extract.
1. Antioxidant and free-radical scavenging
Flavonoids such as baicalein, chrysin, and oroxylin A can:
- Donate electrons to neutralize reactive oxygen species (ROS).
- Upregulate endogenous antioxidant enzymes like superoxide dismutase, catalase, and glutathione-related enzymes.
- Help protect lipids, proteins, and DNA from oxidative damage.
Because oxidative stress is linked to neurodegeneration, vascular damage, and metabolic dysfunction, this antioxidant activity is one of the most relevant mechanisms.
2. Anti-inflammatory signaling
Experimental models show that Oroxylum indicum extracts and isolated flavonoids can modulate inflammatory pathways by:
- Down-regulating NF-κB, a central transcription factor that drives many pro-inflammatory genes.
- Reducing pro-inflammatory cytokines such as TNF-α and IL-1β.
- Lowering inducible enzymes like COX-2 and iNOS that generate inflammatory mediators and reactive nitrogen species.
In the brain, this may translate into lower microglial activation and less neuroinflammation, both of which are implicated in cognitive decline.
3. Neurotransmitter and receptor effects
Oroxylin A, in particular, has several interesting actions in pre-clinical studies:
- Inhibition of dopamine reuptake, which can increase synaptic dopamine levels and potentially support motivation, attention, and learning.
- Modulation of GABA-A receptors, tending to act as a functional antagonist at certain sites. This might promote wakefulness and cognitive alertness, although in excess it could in theory provoke agitation or insomnia in sensitive individuals.
Baicalein and chrysin may act as positive allosteric modulators of GABA-A receptors at other binding sites, which creates a complex, possibly balancing, interaction within the standardized extract.
4. Brain-derived neurotrophic factor (BDNF) and synaptic plasticity
Recent cell studies using standardized Oroxylum indicum bark extract show:
- Increased expression of BDNF in neuronal cells, even under inflammatory stress.
- Activation of pathways such as CaMKIV-CREB and cAMP-responsive signaling, which are central to learning and memory processes.
BDNF supports the growth, survival, and synaptic remodeling of neurons, so any safe upregulation is of high interest in cognitive health.
5. Metabolic and vascular support
Other lines of research suggest:
- Possible improvements in glucose handling and insulin sensitivity.
- Protection of vascular endothelium against oxidative and inflammatory injury.
While these effects are less well established in humans, they may contribute indirectly to cognitive benefits by supporting brain blood flow and metabolic resilience.
Overall, Oroxylum indicum extract seems to combine antioxidant, anti-inflammatory, neurotrophic, and neuromodulatory actions, particularly in relation to dopamine, GABA, and BDNF. The net effect in humans likely depends on dose, duration, and individual brain chemistry.
Benefits of Oroxylum indicum extract
Because research is still developing, it is helpful to separate what has human evidence from pre-clinical or traditional indications.
Cognitive function and memory
A 12-week randomized, double-blind, placebo-controlled trial in older adults with self-reported mild cognitive complaints used 500 mg of standardized Oroxylum indicum bark extract twice daily. The extract group showed:
- Greater improvements in episodic memory, particularly immediate word recall and numeric working memory.
- Faster learning on a visuospatial memory task.
- No major differences on global cognitive screening scores compared with placebo.
Participants overall tolerated the extract well, with slightly more reports of mild digestive issues and headache.
This trial suggests that standardized Oroxylum indicum extract may be helpful for:
- Adults noticing early subjective memory decline, especially in learning lists, names, or locations.
- Supporting concentration and working memory under cognitive load.
However, this is just one study, so results need replication and extension to other populations (e.g., more advanced age, clearly diagnosed mild cognitive impairment, or comorbid conditions).
Neuroprotection and brain aging (pre-clinical)
Cell and animal studies indicate that Oroxylum indicum extracts and its flavonoids may:
- Protect neurons against oxidative stress and inflammatory insults.
- Increase BDNF expression, which supports neuronal survival and synaptic plasticity.
- Improve behavioral performance in models of memory impairment and neurodegeneration.
These findings align with the idea of Oroxylum indicum extract as a neuroprotective botanical, but direct translation to human brain aging remains to be demonstrated.
Traditional uses and systemic effects
Beyond cognition, traditional and experimental work has reported effects that may or may not hold for standardized modern extracts:
- Anti-inflammatory and analgesic activity, relevant for joint and musculoskeletal discomfort.
- Hepatoprotective and gastroprotective actions in certain models, which historically supported its use for liver and digestive disorders.
- Metabolic and antidiabetic potential, including α-glucosidase inhibition and improved glucose markers in animals.
- Antimicrobial and anticancer activity in vitro and in animal models.
At present, cognitive support and neuroprotection are the best characterized potential benefits for standardized bark extracts. Other uses should still be considered experimental and secondary.
Who might consider it (with medical guidance)?
- Adults with mild, self-noticed memory or focus issues who have already addressed basics such as sleep, nutrition, exercise, and medication review.
- Individuals interested in combining evidence-based lifestyle strategies with a cautiously chosen nootropic botanical.
- People exploring Ayurvedic-inspired support for healthy brain aging, under the supervision of a clinician familiar with both herbal medicine and their medical history.
Oroxylum indicum extract should not be regarded as a stand-alone treatment for any neurological or psychiatric condition.
How to use Oroxylum indicum extract
Because products vary, practical use should focus on standardization, dose form, timing, and combination strategy.
1. Choosing a preparation
When evaluating a supplement, look for:
- Clear labeling of plant part (preferably stem bark for alignment with human data).
- Extraction details (e.g., hydroalcoholic extract) and any excipients.
- Standardization to specific percentages of baicalein, chrysin, and oroxylin A, usually stated on the label or technical documents.
Avoid products that list Oroxylum indicum only as a generic “proprietary blend” without standardization, especially at very low total milligram amounts, since the active flavonoid dose may then be unknown.
2. Single-ingredient vs combination formulas
Oroxylum indicum extract appears in:
- Stand-alone capsules or tablets, often marketed for cognitive support.
- Multi-herb nootropic blends, combined with ingredients such as bacopa, ginkgo, or phosphatidylserine.
- Ayurvedic formulas, where it is one component among many.
Single-ingredient standardized products make it easier to:
- Match doses to trial protocols.
- Observe any side effects or benefits without confounding from other herbs.
Combination formulas may be useful, but they complicate interpretation and interaction risk.
3. Timing with meals and daily schedule
In trials, Oroxylum indicum extract is usually taken with food, which can:
- Improve tolerability, especially for people prone to reflux or nausea.
- Potentially influence absorption of flavonoids, which are moderately lipophilic.
Because of its potential dopaminergic and GABA-modulating actions, many users prefer:
- Morning and early afternoon dosing rather than evening, to minimize any chance of insomnia or overstimulation.
- Avoidance of taking it right before bedtime until personal response is known.
4. Duration of use
Clinical data so far:
- A 12-week supplementation period is the best-documented timeframe for cognitive outcomes.
A pragmatic approach with medical guidance could be:
- Trial period of 8–12 weeks at a consistent daily dose.
- Reassessment of cognitive performance, mood, sleep, and any side effects.
- Decision about continuation, dose adjustment, or discontinuation based on benefit–risk balance.
Long-term continuous use beyond a few months has not yet been systematically studied in humans.
5. Stacking with lifestyle interventions
Oroxylum indicum extract should sit on top of, not replace, foundational brain-healthy strategies such as:
- Regular aerobic and resistance exercise.
- Adequate sleep and circadian rhythm support.
- Nutrient-dense diet rich in polyphenols, omega-3 fatty acids, and fiber.
- Cognitive challenges, social engagement, and stress management.
In many cases, a modest-effect supplement shows its true value only when integrated into a comprehensive plan.
Oroxylum indicum extract dosage and timing
Because there is no universally accepted therapeutic dose, it is most responsible to anchor recommendations to studied regimens and then outline cautious ranges.
Doses used in human research
The main completed clinical trial used:
- 500 mg of standardized Oroxylum indicum bark extract, twice daily
- Total daily intake: 1,000 mg/day
- Duration: 12 weeks
- Population: older adults with self-reported mild cognitive impairment
The extract used was standardized for baicalein, chrysin, and oroxylin A at roughly 31% total flavonoids. This means the actual daily flavonoid intake was in the low hundreds of milligrams across all three compounds.
Ongoing and planned clinical trials are exploring 250–500 mg per day in different designs, sometimes combined with bioavailability enhancers such as black pepper extract.
Practical supplemental ranges
For standardized bark extract (with defined flavonoid content), a cautious, commonly used range is:
- Low range: 250–500 mg once daily with food.
- Moderate range: 250–500 mg twice daily (500–1,000 mg/day total).
Going beyond 1,000 mg/day in humans currently lacks robust evidence and should only be considered under expert supervision in a research setting.
Titration strategy
For sensitive individuals or those on multiple medications, a gradual approach is advisable:
- Start with 250 mg once daily with breakfast for 1–2 weeks.
- If well tolerated, increase to 250 mg twice daily (breakfast and lunch).
- If additional benefit is desired and no side effects arise, consider 500 mg in the morning and 250–500 mg at midday, not exceeding 1,000 mg/day without medical oversight.
Special populations and adjustments
- Older adults (65+): Often start at the lower end (250 mg/day), with careful monitoring of blood pressure, sleep, appetite, and any new symptoms.
- People with low body weight: Lower doses may achieve similar plasma levels; starting low becomes more important.
- Those with liver or kidney impairment: Because metabolism and clearance of flavonoids may be altered, use is generally not recommended unless a specialist explicitly approves and monitors it.
Timing relative to other substances
To minimize interaction risks:
- Take the extract separately from sedatives, hypnotics, or strong GABAergic agents, as theoretical GABA-A modulation could interact with their effects.
- If using alongside stimulants (prescribed or high caffeine intake), monitor for restlessness, anxiety, or palpitations.
- For people on blood thinners or antiplatelet drugs, take at a consistent time each day and report any unusual bruising or bleeding promptly to a clinician.
As with any herbal supplement, dosage should be individualized, and any long-term regimen ought to be supervised by a healthcare practitioner, especially in the presence of chronic illness or polypharmacy.
Side effects, safety, and who should avoid it
A balanced view of Oroxylum indicum extract must weigh encouraging efficacy signals against the still limited safety database.
Side effects observed in human studies
In the 12-week randomized trial of standardized bark extract (1,000 mg/day):
- Most participants reported no adverse events.
- The extract group had a slightly higher frequency of mild side effects than placebo, mainly:
- Digestive complaints (loose stools, nausea, bloating)
- Headaches
- No serious adverse events were reported.
- Vital signs, including blood pressure, did not show clinically meaningful between-group differences.
Based on this, Oroxylum indicum extract appears reasonably well tolerated in otherwise healthy older adults over 3 months.
Animal and pre-clinical safety data
Several toxicity studies provide additional context:
- Flavonoid-enriched leaf fraction: Single and repeated doses up to 2,000 mg/kg in rats did not produce mortality, major organ pathology, or neurotoxicity over 28 days in a protocol aligned with OECD guidelines.
- Fruit extracts: At very high doses (2,000 mg/kg) in rats, some evidence of hepatotoxic changes (including fatty liver) emerged, suggesting that extremely high exposures, especially from certain plant parts, can stress the liver.
These findings imply a wide margin between typical human supplemental doses and doses causing harm in rodents, but they do not eliminate concern for long-term or high-dose use in humans.
Potential risks and unknowns
Key uncertainties include:
- Long-term safety: Human data beyond 12–16 weeks are limited.
- Reproductive safety: There are no robust human studies in pregnancy or breastfeeding.
- Drug interactions: Flavonoids can affect drug-metabolizing enzymes and transporters, raising theoretical interaction risks with certain medications.
Because Oroxylum indicum flavonoids modulate neurotransmitter systems and inflammatory pathways, caution is especially warranted in people with complex neurological, psychiatric, or autoimmune conditions.
Who should avoid or use only under close supervision?
It is prudent to avoid Oroxylum indicum extract, or use it only under specialist care, in the following situations:
- Pregnancy and breastfeeding: Insufficient safety data.
- Significant liver disease (e.g., cirrhosis, active hepatitis, unexplained chronic elevation of liver enzymes), due to both traditional hepatic indications and high-dose animal hepatotoxicity signals from some extracts.
- History of seizure disorders or severe psychiatric conditions, especially where GABA or dopamine systems play a key role, unless a neurologist or psychiatrist approves.
- Concurrent use of certain medications, for example:
- Benzodiazepines or other GABAergic sedatives.
- Antiepileptic drugs.
- Anticoagulants and antiplatelet agents (because of theoretical interactions with flavonoids).
- Strongly metabolized narrow-therapeutic-index drugs where any alteration in liver enzyme activity could be problematic.
Sensible monitoring
If a clinician approves a trial of Oroxylum indicum extract, monitoring may include:
- Baseline and follow-up liver function tests for higher-risk individuals or prolonged use.
- Symptom tracking for headaches, gastrointestinal issues, sleep changes, mood shifts, or palpitations.
- Periodic reassessment of whether the perceived benefit justifies continuing the supplement.
Stopping the supplement and seeking prompt medical advice is advisable if any of the following occur:
- Persistent or worsening abdominal pain, dark urine, or jaundice.
- New or worsening anxiety, agitation, or severe insomnia.
- Any neurological symptoms such as tremor, unusual movements, or seizures.
Used judiciously and under professional guidance, standardized Oroxylum indicum extract appears to have a reasonable safety profile, but it is not risk-free.
Research on Oroxylum indicum extract
The scientific literature on Oroxylum indicum spans ethnobotany, phytochemistry, pharmacology, toxicology, and clinical research. A brief map of key areas helps clarify how strong the current evidence really is.
Ethnomedicine and phytochemistry
Comprehensive reviews of Oroxylum indicum document:
- Its wide distribution across South and Southeast Asia and its importance in traditional systems like Ayurveda, Siddha, and local folk medicines.
- Use of different plant parts (bark, roots, leaves, fruits, seeds) for respiratory, digestive, hepatic, joint, skin, and general tonic indications.
- Identification of more than a hundred phytochemicals, with flavonoids (especially baicalein, chrysin, and oroxylin A) as predominant active molecules in most parts of the plant.
These reviews provide a solid foundation for viewing Oroxylum indicum as a multi-target botanical with systemic effects, but they also highlight variability between plant parts and extraction methods.
Experimental pharmacology
Pre-clinical studies have reported that various extracts and isolated constituents of Oroxylum indicum may exert:
- Antioxidant and free-radical scavenging actions across multiple assay systems.
- Anti-inflammatory, anti-arthritic, and analgesic effects in rodent models of inflammation and pain.
- Hepatoprotective and gastroprotective properties in chemically induced liver and gastric injury models at certain doses.
- Antidiabetic and metabolic benefits, including improved glucose tolerance and modulation of carbohydrate-digesting enzymes.
- Anticancer, antimicrobial, and antiviral activity in vitro, although these are very early-stage and not yet clinically relevant as stand-alone treatments.
Neuroprotection and cognitive research
This is currently the most dynamic area of research for standardized bark extract:
- In vitro work on neuronal cell lines has shown that a standardized Oroxylum indicum extract can upregulate BDNF expression, reduce markers of oxidative stress, and protect cells from inflammatory damage. These effects appear to involve both direct antioxidant actions and modulation of key signaling pathways such as CREB and TrkB.
- In vivo animal models suggest improvements in memory tasks and protection against neurotoxin-induced cognitive deficits, with oroxylin A playing a central role in modulating GABAergic and dopaminergic systems.
- Human RCT evidence currently consists mainly of one 12-week trial in older adults with subjective mild cognitive impairment, using 500 mg of standardized bark extract twice daily. This trial found statistically significant improvements in specific episodic memory tasks and learning speed, with good overall tolerability.
Further clinical trials are underway or planned, including studies examining:
- Effects on cognitive function in people with insulin resistance and mild cognitive impairment.
- Metabolic markers such as HOMA-IR, inflammatory markers, and neurodegeneration-related biomarkers.
Safety and toxicology research
Recent work has focused on defining:
- Acute and subacute toxicity thresholds for different extracts and flavonoid-enriched fractions, with doses up to 2,000 mg/kg in rats generally showing no mortality or major organ pathology for certain preparations.
- Potential hepatotoxicity at very high doses of some fruit extracts, underlining the importance of plant part selection and dose control.
- Neurotoxicity risk, which appears low for flavonoid-enriched leaf fractions at tested doses, with no measurable deficits in behavior or motor function over subacute exposure.
Overall, the research base for Oroxylum indicum extract is promising but incomplete. We have mechanistic plausibility, pre-clinical support, and early human efficacy and safety data, but not yet the volume or diversity of trials needed to regard it as an established therapy. For now, it is best framed as a potentially useful cognitive support adjunct rather than a proven treatment.
References
- Effects of an Oroxylum indicum Extract (Sabroxy) on Cognitive Function in Adults With Self-Reported Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Study 2021 (RCT)
- Oroxylum indicum (L.) Kurz, an important Asian traditional medicine: from traditional uses to scientific data for its commercial exploitation 2015 (Review)
- A Review on the Medicinal and Pharmacological Properties of Traditional Ethnomedicinal Plant Sonapatha, Oroxylum indicum 2021 (Systematic-style Review)
- Acute Toxicity of Oroxylum indicum Fruit Extracts in Rats 2021 (Toxicology Study)
- Pre-clinical acute oral toxicity and subacute neurotoxicity risk assessments on Sprague Dawley rats treated with single dose or repeated doses of flavonoid-enriched fraction extracted from Oroxylum indicum leaves 2025 (Toxicology Study)
- The Neuroprotective Effects of Oroxylum indicum Extract in SHSY-5Y Neuronal Cells by Upregulating BDNF Gene Expression under LPS Induced Inflammation 2024 (Experimental Study)
Disclaimer
The information in this article is intended for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. Oroxylum indicum extract is not approved to prevent, treat, or cure any disease. Never start, stop, or change any medication or supplement regimen without consulting a qualified healthcare professional who is familiar with your medical history, current diagnoses, and prescriptions. If you have symptoms of cognitive decline, neurological disease, liver problems, or any other serious health condition, seek in-person medical evaluation promptly.
If you found this guide useful, you are welcome to share it with others on Facebook, X (formerly Twitter), or any platform you prefer, and to follow our work on social media. Thoughtful sharing helps support our team’s ability to continue producing carefully researched, high-quality health content. Thank you for your support.
